-
Leerink Starts Seaport Therapeutics (SPTX) at Outperform
-
JPMorgan Starts Seaport Therapeutics (SPTX) at Overweight
-
Stifel Starts Seaport Therapeutics (SPTX) at Buy
-
Goldman Sachs Starts Seaport Therapeutics (SPTX) at Early-Stage Biotech
-
Seaport Therapeutics files 11.8M share IPO at $16-$18/sh
-
Seaport Therapeutics files for proposed IPO

